Labaran masana'antu
-
Semaglutide ba kawai don asarar nauyi ba ne
Semaglutide magani ne mai rage glucose wanda Novo Nordisk ya haɓaka don kula da nau'in ciwon sukari na 2. A cikin Yuni 2021, FDA ta amince da Semaglutide don tallata azaman maganin asarar nauyi (sunan ciniki Wegovy). Magungunan shine glucagon-kamar peptide 1 (GLP-1) agonist mai karɓa wanda zai iya kwaikwayi tasirin sa, ja ...Kara karantawa -
Menene Mounjaro (Tirzepatide)?
Mounjaro (Tirzepatide) magani ne don asarar nauyi da kiyayewa wanda ya ƙunshi abu mai aiki tirzepatide. Tirzepatide shine GIP dual dual da GLP-1 agonist mai karɓa. Dukansu masu karɓa ana samun su a cikin alpha pancreatic da beta endocrin sel, zuciya, tasoshin jini, ...Kara karantawa -
Tadalafil Application
Tadalafil magani ne da ake amfani da shi don magance tabarbarewar mazakuta da wasu alamun bayyanar prostate mai girma. Yana aiki ta hanyar inganta kwararar jini zuwa azzakari, yana bawa mutum damar cimmawa da kuma kula da tsauri. Tadalafil na cikin nau'in magungunan da aka sani da nau'in phosphodiesterase 5 (PDE5) inhibitors, ...Kara karantawa -
Faɗakarwar Sabbin Kayayyaki
Don samar da ƙarin zaɓuɓɓuka ga abokan ciniki a cikin masana'antar peptides na kwaskwarima, Gentolex koyaushe zai ƙara sabbin samfura cikin jerin. Babban inganci tare da nau'ikan iri iri, akwai jerin abubuwa huɗu daban-daban ta ayyuka a cikin kare fatalwar, ciki har da anti-tsufa, ...Kara karantawa -
Ci gaban bincike na peptides na opioid daga amincewar Difelikefalin
Tun daga 2021-08-24, Cara Therapeutics da abokin kasuwancin sa Vifor Pharma sun ba da sanarwar cewa kappa opioid mai karɓar agonist difelikefalin (KORSUVA™) FDA ta amince da shi don kula da cututtukan koda na yau da kullun (CKD) marassa lafiya mai matsakaici / matsananciyar pruritus tare da hemod.Kara karantawa